News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health problems news

Show

From To
Mental and emotional health problems
One in five Americans living with HIV experience severe anxiety on an almost daily basis

A fifth of HIV-positive adults in the United States regularly experience symptoms of anxiety, according to research published in AIDS. Individuals with symptoms of generalised anxiety disorder (GAD)

Published
04 July 2019
By
Michael Carter
Cardiovascular disease
HIV infection may increase heart failure and stroke risk

A Journal of the American Heart Association analysis of information from a large health insurance database reveals that people living with HIV have an elevated risk of developing cardiovascular disease (CVD), particularly heart failure and stroke. The findings indicate that increased efforts to protect patients' cardiovascular health are needed.

Published
03 July 2019
From
EurekAlert
Cancer
Rising Above: People living with HIV are also facing cancer as they age

As a long-term survivor living with HIV, Sean McKenna has faced numerous battles, including two episodes of skin cancer and several bouts of anal precancer. Jill Cadman, another long-timer, is living with HIV and Stage IV colon cancer. And they are not alone.

Published
02 July 2019
From
POZ
Opportunistic infections
Gilead fails to keep promise on access to lifesaving drug for people living with HIV

Pharmaceutical corporation Gilead promised to expand access at an affordable price to a drug for people with an HIV-related infection, cryptococcal meningitis. One year on, the drug is registered in only six developing countries and remains prohibitively expensive.

Published
01 July 2019
From
Médecins Sans Frontières
Kidney problems
Patients with HIV less likely to be waitlisted for kidney transplant

Patients with HIV were less likely to be placed on the kidney transplant waitlist than patients without HIV, according to research presented at the American Transplant Congress. They also experienced longer wait-times from evaluation to listing.

Published
25 June 2019
From
Healio
Cardiovascular disease
Efavirenz Dose Reduction Improves Lipid Profile in Adults With HIV-1

The researchers concluded that “a reduced dose of efavirenz (a 400 mg dose is now recommended as an alternative first-line regimen also by [World Health Organization] can lead to a significant decline in total cholesterol and LDL and should be used especially in patients with cardiovascular or metabolic comorbidities.”

Published
19 June 2019
From
Infectious Disease Advisor
Drug interactions and pharmacokinetics
Frequent drug-drug interactions in older people with HIV in France

Drug-drug interactions are common in people over the age of 65 living with HIV and this substantially increases healthcare costs in France. Published in Open Forum Infectious Diseases,

Published
19 June 2019
By
Alain Volny-Anne
PrEP science
Truvada as PrEP Tied to Only Modest Bone Density Decline

A new analysis also found a correlation between higher adherence to the daily drug regimen and greater bone density loss.

Published
17 June 2019
From
POZ
Cardiovascular disease
Performance of CVD Risk Prediction Algorithms in People Living With HIV

Algorithms may help predict cardiovascular disease (CVD) risk in people living with HIV (PLWHIV), according to a study published in the Journal of Acquired Immune Deficiency Syndromes.

Published
11 June 2019
From
Infectious Disease Advisor
Chemsex and recreational drug use
Australia's Therapeutic Goods Administration decides not to ban poppers

Australia’s Therapeutic Goods Administration (TGA) has been praised for backing down on an outright ban of “poppers”.

Published
10 June 2019
From
QN
← Prev12345...233Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.